Synthesis of deuterium-labeled celecoxib and its metabolites-Reference-Cited by-同舟云学术

Synthesis of deuterium-labeled celecoxib and its metabolites

Published:2023-11-14 Issue:12 Volume:332 Page:5045-5050
ISSN:0236-5731
Container-title:Journal of Radioanalytical and Nuclear Chemistry
language:en
Short-container-title:J Radioanal Nucl Chem

Author:

He Mei,Xiang Geng,Duan Longqiang,Li JuLong,Tian Lei^ORCID

Funder

CNPC Research Institutes Safety & Environmental Technology Programme

National Natural Science Foundation of China

PetroChina Innovation Foundation

Nature Science Foundation of Hubei Province

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology, Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry

Link

https://link.springer.com/content/pdf/10.1007/s10967-023-09242-3.pdf

Reference24 articles.

1. Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387–437

2. O’Banion MK, Sadowski HB, Winn V, Young DA (1991) A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266(34):23261–23267

3. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266(20):12866–12872

4. Goldstien JL, Silverstein FE, Agrawal NM et al (2000) Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95(6):1681–1690

5. Vane JR, Bakhe YS, Botting RM (1998) CYCLOOXYGENASES 1 and 2. Ann Rev Pharmacol Toxicol 38:97–120